Skip to main content

Table 2 NETs as a valuable marker in Cancer from the clinical perspective

From: Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target

Year

Method

Samples number

Chosen markers of NETs

Type of Cancer

Function

Reference

2016

ELISA

35

MPO-DNA complex

Colorectal cancer

correlated with the reduction in DFS

[42]

2018

ELISA

161

Citrullinated histone H3

Pan-cancer

prognostic blood marker

[109]

2019

ELISA

45

NE-DNA complex

Breast cancer

associated with clinical stages

[117]

2019

ELISA

27

MPO-DNA complex

Colorectal cancer

correlated with shorter survival

[41]

2019

ELISA

104

MPO-DNA complex

Pancreatic ductal adenocarcinoma

related to the clinical stage

[19]

2019

ELISA

957

Citrullinated histone H3

Pan-cancer

associated with higher mortality

[110]

2019

IHC

317

Citrullinated histone H3

Pancreatic ductal adenocarcinoma

prognostic factor

[113]

2019

ELISA

138

circulating DNA

Pan-cancer

related to cancer-related stroke

[114]

2019

ELISA

75

MPO-DNA complex

Esophagogastric and lung adenocarcinoma

correlated with advanced stage

[106]

2020

ELISA

356

NE-DNA complex

Gastric Adenocarcinoma

diagnostic, therapeutic predictive, and prognostic value

[108]

2020

ELISA

461

MPO-DNA complex

Breast cancer

metastases predictor

[11]

2022

IHC

321

MPO

Pan-cancer

prognostic factor

[13]

2022

ELISA

25

MPO-DNA complex

Breast cancer

monitoring HER2 antibody–drug-associated vasculitis activity

[116]